pharmacogenomic testing and breast cancer: the example of cyp2d6 and tamoxifen - dr. hannah linden
Published 10 years ago • 1.1K plays • Length 40:09Download video MP4
Download video MP3
Similar videos
-
14:37
genomic testing in breast cancer: what you must know
-
3:16
new diagnostic tool in battle against breast cancer l gma
-
3:32
precision survivorship medicine in breast cancer
-
1:47
can we decrease chemotherapy in ln premenopausal women based on genomic tests?
-
58:32
molecular testing in breast cancer: will it become standard practice?
-
8:10
8 signs you’re perimenopausal with menopause nutritionist emma bardwell
-
2:45
what is tamoxifen, it's uses & side effects – dr. berg
-
10:06
triple negative breast cancer: what you need to know
-
0:44
professor geoff lindeman: an existing medicine may prevent breast cancer in at-risk women
-
1:43
fda approves home test for breast-cancer gene | abc7
-
1:31
mayo clinic: don’t change breast cancer guidelines on flawed research
-
3:06
breast cancer detection and treatment: compass oncology
-
1:20:03
webinar on liquid biopsy for cancer diagnostics & therapeutic monitoring
-
16:56
s1e06: continuing the fight against breast cancer
-
0:46
johns hopkins students' device aims to avert repeated breast cancer surgeries
-
2:21
testing for breast cancer recurrence
-
2:42
what is breast cancer genomic testing?
-
1:07
ask unmc. tomoxifen and breast cancer.
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
1:37
cancer expert explains testing in breast cancer video
-
0:29
join us for breast cancer seminar with a/prof christine chaffer